Hanson Wade

R&D

Partner Content

Advance Modified TIL Therapies, Optimize TIL Characterization, Gene Engineering & Streamline Manufacturing

R&D

Partner Content

The 2nd Process Development for Cell Therapies Summit Returns to Boston June 20-22

R&D

Partner Content

Uniting Key Biopharma and Academics Dedicated to Successfully Developing Exosome-Based Therapeutics

Oncology

Partner Content

Engineering a Disease Free World

R&D

Partner Content

Spearheading Degrader Therapeutics Towards the First Approval

R&D

Partner Content

Accelerate Oligonucleotide Approval with Tightened QC & Quality